Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics 2023-09-08 15:30
World Orphan Drug Alliance Welcomes Specialised Therapeutics 2023-09-08 04:00
SOAP Health and AESOP Technology Unite to Provide Advanced AI Solutions for Clinical Decision-Support and Medical Coding 2023-09-07 21:00
Isotopia Issues a call to action to the radionuclide Therapy industry. 2023-09-06 20:40
Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer 2023-09-06 19:00
CANbridge to Participate in Two Investor Conferences in September 2023-09-06 16:06
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile 2023-09-05 20:00
I-Mab Announces Upcoming Participation at September Conferences 2023-09-05 20:00
GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS) 2023-09-05 09:57
ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors 2023-09-02 00:00
Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement 2023-09-01 21:30
CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023 2023-08-31 15:15
Tycoon Group Announces 2023 Interim Results 2023-08-31 13:28
LOTTE BIOLOGICS Holds 'ESG Declaration Ceremony' 2023-08-31 09:00
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2023-08-30 14:19
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC 2023-08-30 11:00
Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure 2023-08-30 10:53
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF 2023-08-30 08:03
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:02
1 20 21 22 23 24 147